Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (24)
  • 2024 (29)
  • 2023 (54)
  • 2022 (90)
  • 2021 (71)
  • 2020 (10)
  • 2019 (6)
  • 2018 (2)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Press Conferences (68)

Drug Name

  • Fentanyl (64)
  • Opioids (51)
  • Oxycodone (49)
  • Cocaine (23)
  • Methamphetamine (19)
  • Synthetic Opioids (17)
  • Heroin (13)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Marijuana (Cannabis) (2)
  • Ecstasy/MDMA (1)
  • GHB (1)

Field Division

  • Washington, DC (55)
  • St. Louis (33)
  • New York (23)
  • Chicago (20)
  • Sede (18)
  • New Jersey (17)
  • Miami (16)
  • El Paso (13)
  • Atlanta (12)
  • Seattle (12)
  • Dallas (11)
  • Houston (9)
  • Rocky Mountain (7)
  • San Francisco (7)
  • New England (6)
  • New Orleans (6)
  • Los Angeles (5)
  • Louisville (5)
  • Omaha (5)
  • San Diego (5)
  • Phoenix (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Supplier in Juvenile Fentanyl Overdoses Case Charged with Drug Conspiracy

Febrero 15, 2023
DALLAS, TEXAS - A top source of supply in the Carrollton fentanyl overdoses case has been charged with a federal drug crime, announced U.S. Attorney for the Northern District of Texas Leigha Simonton. Jason Xavier Villanueva, 22, was charged via criminal complaint with conspiracy to distribute a Schedule II controlled...
Febrero 15, 2023
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

Febrero 15, 2023
NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
Febrero 15, 2023
PRESS RELEASE

Missouri Doctor Admits Diluting Clinic’s Methadone

Febrero 03, 2023
ST. LOUIS - A doctor admitted on Friday that he diluted methadone that was dispensed in a St. Francois County, Missouri, methadone clinic in 2021. Dr. Sunil G. Chand, 59, pleaded guilty in front of U.S. District Judge Sarah E. Pitlyk to one count of adulterating a drug with the...
Febrero 03, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Enero 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
Enero 24, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Enero 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
Enero 24, 2023
PRESS RELEASE

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics

Enero 11, 2023
MIAMI – Dr. Ronald Lubetsky was sentenced this week to five (5) years in prison by U.S. District Judge Donald M. Middlebrooks for unlawfully dispensing narcotics—specifically oxycodone and morphine. Lubetsky was convicted at trial in November on seven counts of unlawfully dispensing narcotics. Trial evidence showed that law enforcement learned...
Enero 11, 2023
PRESS RELEASE

Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations

Enero 06, 2023
COLUMBIA, S.C. – Savitz Drug Store, Inc., has agreed to pay $275,000 to resolve allegations that it committed recordkeeping and dispensing violations of the Controlled Substances Act (CSA). These requirements are designed to prevent the diversion of controlled substances. This civil settlement includes a corrective action plan and is the...
Enero 06, 2023
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

Diciembre 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
Diciembre 29, 2022
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

Diciembre 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
Diciembre 15, 2022
Showing 101 - 110 of 289 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 7
  • Página 8
  • Página 9
  • Página 10
  • Current page 11
  • Página 12
  • Página 13
  • Página 14
  • Página 15
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster